/images/headbanner/42-PeptideService.jpg
Peptide Process Development and Manufacturing
Head Banner
“One-stop” peptide platform

Our comprehensive peptide platform provides our global customers a truly one-stop CRDMO solution from drug discovery to CMC development and manufacturing. Please click here to access our dedicated peptide website to learn our integrated services including unnatural amino acid, peptides and their conjugate, API to drug product.


In our Changzhou facility, we have built an integrated peptide process R&D and manufacturing platform to support you from preclinical to commercial. Until now, we completed 40+ peptide projects, two PPQ enabling studies, two  PPQ campaigns, and delivered large-scale peptide projects of ~40kg/batch. 

/media/150737/new_modality.jpg
#EFEFEF
HQArticle_Head
Our key advantages


• Scalability – From discovery to development and commercialization all within WuXi
• Conjugation chemistry – Conjugations with small molecule linker, oligo/peptide or antibody  
• Solid phase and solution phase chemistry - Built upon WuXi’s industry leading process chemistry organization   
• Global quality standard – Quality system approved by major regulatory agencies and partners
• Comprehensive analytical platform – One-stop analytical support in house with state-of-the-art equipment, including unique peptide enantiomeric purity test
• Full value chain offering – Discovery, CMC (drug substance, drug product and analytical), preclinical & clinical trial services
/media/150616/peptide.png
#EFEFEF
HQArticle_Head
中文
EN
  • Home 首页
  • {{menu.Name}} {{menu.Name}}
      • {{twoMenu.Name}} {{twoMenu.Name}}
        • {{threeMenu.Name}} {{threeMenu.Name}}
          • {{fourMenu.Name}}
    • {{twoMenu.Name}}
  • Home 首页
  • EN 中文

{{item.headBannerTitle}}

  • Services & Solutions Overview
  • API Process Development & Manufacturing
  • Formulation Development & Manufacturing
  • Oligonucleotide CRDMO Service
  • Peptide CRDMO Service
  • Analytical Development & Quality Control
  • Global Regulatory Affairs CMC Filing
  • About Us
  • Services and Solutions
  • News
  • Resources
  • Careers
  • Contact us

{{item.title}}

{{item.contentTitle}}

{{item.contentTitle}}

Click to learn more

{{item.title}}

{{item.title}}

{{secondGrids.title}}

{{item.table.title}}

  • {{grid.text}}

{{item.table.title}}

  • {{grid.text}}

{{item.title}}

{{item.content}}

  • {{art.subTitle}}

{{item.title}}

{{item.leftContent.title}}

{{item.rightContent.title}}

{{fa.title}}

{{fa.subTitle}}

{{fa.title}}

{{fa.subTitle}}

{{item.title}}

{{item.content}}

{{fa.title}}

{{item.title}}

{{item.title}}

{{art.articleTitle}}

{{art.articleContent}}

{{item.title}}

{{item.contentTitle}}

{{item.contentTitle}}

Click to learn more

  • About Us
  • News
  • Resource
  • Careers
  • Contact Us

Services & Solutions

  • API Process Development & Manufacturing
  • Drug Product Development & Manufacturing
  • Oligonucleotide CRDMO Service
  • Peptide CDRMO Service
  • Analytical Development & Quality Control
  • Global Regulatory Affairs CMC Support
  • 关于我们
  • 新闻和活动
  • 资源中心
  • 职业发展
  • 联系我们

服务和解决方案

  • 原料药工艺研发与生产
  • 制剂工艺研发与生产
  • 寡核苷酸
  • 多肽服务
  • 分析开发与质量控制
  • 全球申报事务药学支持

领英

药明康德

Copyright © 2020 STA Pharmaceutical Co. Ltd. Privacy Policy 隐私策略 Terms of Use 使用条款 沪公网安备 31011502018943号